http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2508907-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c646f75c4f7c6349f35c8fe01934921
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38
filingDate 1982-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2712fbc3311f345d75951db2e53f13c
publicationDate 1983-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2508907-A1
titleOfInvention HYDROXYBENZENE ESTERS SUBSTITUTED WITH 2-THENOYLMERCAPTOPROPIONYLGLYCIN USEFUL AS MUCOLYTICS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
abstract THE INVENTION CONCERNS HYDROXYBENZENES ESTERS SUBSTITUTED FOR 2-THENOYLMERCAPTOPROPIONYLGLYCIN OF GENERAL FORMULA (I) (CF DRAWING IN BOPI) IN WHICH R IS A RADICAL P-ACETAMIDOPHENYL, P-ACETAMIDOPHENYL, P-ACETAMIDOPHENYL, P-ACETAMIDOPHENYL RADICAL, P-ACETAMIDOPHENYL, P-ACETAMIDOPHENYL, P-ACETAMIDOPHENYL, P-ACETAMIDOPHENYL, ORKYB-PROXYL-PROXYL-O-RADOHYC-O-RADOHYL-P-ACETAMIDOPHENYL, ORKYB-PROXYC-O-RADOPYLOXOPYLOXYL-P-O-PARBALOPHENYL, P-ACETAMIDOPHENYLE IS IN CC. APPLICATIONS: PREPARATION OF USEFUL MEDICINES ESPECIALLY AS MUCOLYTIC AND ANTI-INFLAMMATORY AGENTS.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9113883-A1
priorityDate 1981-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0013261-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0044504-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2422657-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID264260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54151966
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420809113
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86676953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415860614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432306167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421462170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140333937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415803338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412202640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522973
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID98681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430824729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424624196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4754

Total number of triples: 51.